IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of t

GOTHENBURG, SWEDEN / ACCESSWIRE / May 6, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 6, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the Swedish Medical Products Agency has ap...

Related Keywords

China ,Stockholm ,Sweden ,South Korea ,Gothenburg ,Vastra Gotalands Lan ,Japan ,Canada ,Swedish ,Gunnar Olsson ,Joakim Tedroff ,Arvid Carlsson ,Michaelj Fox Foundation For Parkinson Research ,Swedish Medical Products Agency ,Michaelj Fox Foundation ,Nasdaq Stockholm ,Chief Medical Officer ,Nobel Laureate ,Integrative Screening Process ,